Scarring in the heart - A reversible phenomenon?

New England Journal of Medicine

Volumn 357, Issue 17, 2007, Pages 1767-

  Towbin, Jeffrey A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARDIOMYOPATHY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIA; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

EID: 35548968013     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr075397     Document Type: Article

References (4)

1. Zeisberg EM, Tarnavaski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-61.
2. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Nielson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-50.
3. Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 1995;77:1-6.
4. Bujak M, Frangogiannis NG. The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-95.